Психические расстройства в общей медицине. №2 2011

Значение психических факторов в клинике внутренних болезней

Ф.И.Белялов

Иркутский государственный институт усовершенствования врачей

Стр. 4-8

2003 просмотров

Опубликовано: 1 февраля 2011

Аннотация / Abstract

Резюме. В аналитической работе обобщены основные результаты исследований в области коморбидных психических и соматических заболеваний. Показана тесная двунаправленная связь соматических заболеваний и состояния психики, необходимость диагностирования и лечения психических расстройств у пациентов с соматическими заболеваниями. Ключевые слова: психические расстройства, психосоматика, внутренние болезни. Mental health disorders in practice of internists F.I.Belyalov Irkutsk State Institute for Postgraduate Training of Physicians Summary. Author reviewed contemporary studies of mental health disorders in practice of internists. There are bidirectional relations between somatic diseases and psychiatric status and disorders. Trained general practitioners may reveal and treat psychiatric disorders in patients with somatic disorders. Key words: mental health disorders, primary care, psychosomatics. Проблема связи душевного состояния и заболеваний внутренних органов длительное время остается предметом многочисленных исследований. Научные работы по психосоматике публикуются не только в специализированных журналах (Psychosomatics, Psychosomatic Medicine), но также в ведущих изданиях по внутренним болезням (New England Journal of Medicine, Archives of Internal Medicine, Circulation, European Respiratory Journal, Gastroenterology, Kidney International и т.д.). В то же время существует дефицит работ, обобщающих накопленный огромный массив научной информации (А.Б.Смулевич и соавт., 2005; L.Levenson, 2004). Следует учесть, что в последние 10–15 лет были повышены требования к качеству научных исследований и, соответственно, многие устоявшиеся представления нуждаются в уточнении. В настоящей работе предпринята попытка обобщить результаты научных исследований в области психосоматических отношений и сформулировать основные положения, характеризующие важные стороны таких отношений. Конечно, невозможно показать...

Материал для специалистов

Полный текст статьи доступен только зарегистрированным пользователям.

Вход / Регистрация

1. Смулевич А.Б., Сыркин А.Л., Дробижев М.Ю., Иванов С.В. Психокардиология. М. 2005.
2. The American Psychiatric Publishing textbook of psychosomatic medicine. Edited by James L.Levenson 2004.
3. Jackson JL, Passamonti M, Kroenke K. Outcome and Impact of Mental Disorders in Primary Care at 5 years. Psychosom Med 2007; 69: 270–6.
4. Sayers SL, Hanrahan N, Kutney A et al. Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. J Am Geriatr Soc 2007; 55 (10): 1585–91.
5. Vamos EP, Mucsi I, Keszei A et al. Comorbid Depression Is Associated With Increased Healthcare Utilization and Lost Productivity in Persons With Diabetes: A Large Nationally Representative Hungarian Population Survey. Psychosom Med 2009; 71 (5): 501–7.
6. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a metaanalysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–74.
7. Ohira T, Iso H, Satoh S et al. Prospective study of depressive symptoms and risk of stroke among japanese. Stroke 2001; 32 (4): 903–8.
8. Pan A, Lucas M, Sun Q et al. Bidirectional Association Between Depression and Type 2 Diabetes Mellitus in Women. Arch Intern Med 2010; 170 (21): 1884–91.
9. Alexander F. Psychosomatic medicine. New York: Norton, 1950.
10. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129–36.
11. Haug TT, Mykletun A, Dahl A. The Association Between Anxiety, Depression, and Somatic Symptoms in a Large Population: The HUNT-II Study. Psychosom Med 2004; 66: 845–51.
12. Pertti A, Nicholas JT, Jukka R et al. Anxiety Is Associated With Uninvestigated and Functional Dyspepsia (Rome III Criteria) in a Swedish Population-Based Study. Gastroenterology 2009; 137: 94–100.
13. Ford AC, Talley NJ, Schoenfeld PS et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and metaanalysis. Gut 2009; 58 (3): 367–78.
14. Frasure-Smith N, Lesperance F. Depression and Anxiety as Predictors of 2-Year Cardiac Events in Patients With Stable Coronary Artery Disease. Arch Gen Psychiatry 2008; 65: 62–71.
15. Ruo B, Rumsfeld JS, Hlatky MA et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290: 215–21.
16. Fontana RJ, Moyer CA, Sonnad S et al. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol 2001; 96 (1): 170–8.
17. Karaivazoglou K, Iconomou G, Triantos C et al. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. Health-related quality of life (HRQOL). Ann Hepatol 2010; 9 (4): 419–27.
18. Ormel J, Petukhova M, Chatterji S et al. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008; 192: 368–75.
19. Moussavi S, Chatterji S, Verdes E et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851–8.
20. Schmitz N, Wang J, Malla A et al. Joint Effect of Depression and Chronic Conditions on Disability: Results From a Population-Based Study. Psychosom Med 2007; 69: 332–8.
21. Kinder LS, Bradley KA, Katon WJ et al. Depression, Posttraumatic Stress Disorder, and Mortality. Psychosom Med 2008; 70: 20–6.
22. Surtees PG, Wainwright NWJ, Luben RN et al. Depression and Ischemic Heart Disease Mortality: Evidence From the EPIC-Norfolk United Kingdom Prospective Cohort Study. Am J Psychiatry 2008; 165: 515–23.
23. Whang W, Kubzansky LD, Kawachi I et al. Depression and Risk of Sudden Cardiac Death and Coronary Heart Disease in Women: Results From the Nurses\' Health Study. J Am Coll Cardiol 2009; 53 (11): 950–8.
24. Osborn DPJ, Levy G, Nazareth I et al. Relative Risk of Cardiovascular and Cancer Mortality in People With Severe Mental Illness From the United Kingdom\'s General Practice Research Database. Arch Gen Psychiatry 2007; 64: 242–9.
25. Meyer T, Buss U, Herrmann-Lingen C. Role of Cardiac Disease Severity in the Predictive Value of Anxiety for All Cause Mortality. Psychosom Med 2010; 72 (1): 9–15.
26. O\'Connor CM, Jiang W, Kuchibhatla M et al. Antidepressant Use, Depression, and Survival in Patients With Heart Failure. Arch Intern Med 2008; 168 (20): 2232–7.
27. Vaccarino AL, Sills TL, Evans KR et al. Multiple Pain Complaints in Patients With Major Depressive Disorder. Psychosom Med 2009; 71 (2): 159–62.
28. Howren MB, Suls J, Martin R. Depressive Symptomatology, Rather than Neuroticism, Predicts Inflated Physical Symptom Reports in Community Residing Women. Psychosom Med 2009; 71 (9): 951–7.
29. Fass R, Naliboff BD, Fass SS et al. The Effect of Auditory Stress on Perception of Intraesophageal Acid in Patients With Gastroesophageal Reflux Disease. Gastroenterology 2008; 134: 696–705.
30. Main J, Moss-Morris R, Booth R et al. The use of reliever medication in asthma: the role of negative mood and symptom reports. J Asthma 2003; 40 (4): 357–65.
31. Ramasamy R, Hildebrandt T, O\'Hea E et al. Psychological and Social Factors That Correlate With Dyspnea in Heart Failure. Psychosomatics 2006; 47: 430–4.
32. Nelson HS, Weiss ST, Bleecker ER et al. The Salmeterol Multicenter Asthma Research Trial: A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol. Chest 2006; 129: 15–26.
33. Kramer JM. Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists – The Influence of Values. New England J of Medicine 2009; 360 (16): 1592–5.
34. Dowrick CF, Bellon JA, Gomez MJ. GP frequent attendance in Liverpool and Granada: the impact of depressive symptoms. Br J Gen Pract 2000; 50 (454): 361–5.
35. Hu WH, Wong WM, Lam CL et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002; 16 (12): 2081–8.
36. Baez K, Aiarzaguena JM, Grandes G et al. Understanding patient-initiated frequent attendance in primary care: a case-control study. Br J Gen Pract 1998; 48 (437): 1824–7.
37. Simpson SH, Eurich DT, Majumdar SR et al. A metaanalysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
38. Martin-Santos R, Diez-Quevedo C, Castellvi P et al. De Novo Depression and Anxiety Disorders and Influence on Adherence During Peginterferon-Alpha-2a and Ribavirin Treatment in Patients With Hepatitis C. Aliment Pharmacol Ther 2008; 27 (3): 257–65.
39. Cukor D, Rosenthal DS, Jindal RM et al. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney International 2009; 75: 1223–9.
40. Davidson KW, Mostofsky E, Whang W. Don\'t worry, be happy: positive affect and reduced 10-year incident coronary heart disease: The Canadian Nova Scotia Health Survey. Eur Heart J 2010; 31 (9): 1065–70.
41. Tsai AC, Weiser SD, Petersen ML et al. A Marginal Structural Model to Estimate the Causal Effect of Antidepressant Medication Treatment on Viral Suppression Among Homeless and Marginally Housed Persons With HIV. Arch Gen Psychiatry 2010; 67 (12): 1282–90.
42. Kim HK, Park JH, Park JH et al. Differences in Adherence to Antihypertensive Medication Regimens According to Psychiatric Diagnosis: Results of a Korean Population-Based Study. Psychosom Med 2010; 72 (1): 80–7.
43. Bogner HR, de Vries HF. Integration of Depression and Hypertension Treatment: A Pilot Randomized Controlled Trial. Ann Fam Med 2008; 6: 295–301.
44. Dickens C, McGowan L, Percival C et al. New Onset Depression Following Myocardial Infarction Predicts Cardiac Mortality. Psychosom Med 2008; 70: 450–5.
45. Surtees PG, Wainwright NWJ, Luben RN et al. Depression and Ischemic Heart Disease Mortality: Evidence From the EPIC-Norfolk United Kingdom Prospective Cohort Study. Am J Psychiatry 2008; 165: 515–23.
46. Rayner L, Price A, Evans A et al. Antidepressants for depression in physically ill people. Cochrane Database of Systematic Reviews 2010, Issue 3.
47. Beltman MW, Voshaar RCO, Speckens AE. Cognitive-behavioural therapy for depression in people with a somatic disease: metaanalysis of randomised controlled trials. Br J Psychiatry 2010; 197 (1): 11–9.
48. Taylor D, Meader N, Bird V et al. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and metaanalyses of safety and efficacy. Br J Psychiatry 2011; 198 (3): 179–88.
49. Van Melle JP, de Jonge P, Honig A et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007; 190: 460–6.
50. Thombs BD, de Jonge P, Coyne JC et al. Depression Screening and Patient Outcomes in Cardiovascular Care: A Systematic Review. JAMA 2008; 300 (18): 2161–71.
51. de Jonge P, Honig A, van Melle JP et al. Nonresponse to Treatment for Depression Following Myocardial Infarction: Association With Subsequent Cardiac Events. Am J Psychiatry 2007; 164: 1371–8.
52. de Abajo FJ, Garcia-Rodriguez LA. Risk of Upper Gastrointestinal Tract Bleeding Associated With Selective Serotonin Reuptake Inhibitors and Venlafaxine Therapy. Arch Gen Psychiatry 2008; 65: 795–803.
53. Joseph KS, Blais L, Ernst P, Suissa S. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 1996; 312 (7023): 79–82.
54. Fukuhara S, Green J, Albert J et al. Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney International 2006; 70: 1866–72.
55. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network metaanalysis. Lancet 2007; 369: 201–7.
56. Rubin RR, Ma Y, Marrero DG et al. Elevated Depression Symptoms, Antidepressant Medicine Use, and Risk of Developing Diabetes During the Diabetes Prevention Program. Diabetes Care 2008; 31: 420–6.
57. Kroenke K, Bair MJ, Damush TM et al. Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal Pain: A Randomized Controlled Trial. JAMA 2009; 301 (20): 2099–110.
58. Sayers SL, Hanrahan N, Kutney A et al. Psychiatric comorbidity and greater hospitalization risk, longer length of stay and higher hospitalization costs in older adults with heart failure. J Am Geriatr Soc 2007; 55 (10): 1585–91.
59. Albert NM, Fonarow GC, Abraham WT et al. Depression and Clinical Outcomes in Heart Failure: An OPTIMIZE-HF Analysis. Am J Med 2009; 122: 366–73.
60. Vamos EP, Mucsi I, Keszei A et al. Comorbid Depression Is Associated With Increased Healthcare Utilization and Lost Productivity in Persons With Diabetes: A Large Nationally Representative Hungarian Population Survey. Psychosom Med 2009; 71 (5): 501–7.
61. Siskind D, Araya R, Kim J. Cost-effectiveness of improved primary care treatment of depression in women in Chile. Br J Psychiatry 2010; 197 (4): 291–6.
62. Wang J, Patten SB. Perceived Effectiveness of Mental Health Care Provided by Primary-Care Physicians and Mental Health Specialists. Psychosomatics 2007; 48: 123–7.
63. Albus C, Jordan J, Herrmann-Lingen C. Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice. Eur J Cardiovasc Prev Rehabil 2004; 11 (1): 75–9.
64. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a metaanalysis. Lancet 2009; 374: 609–19.

ЖУРНАЛЫ

ИНТЕРАКТИВ

СПЕЦИАЛИЗАЦИИ

ИЗДАНИЯ-ПАРТНЕРЫ

Значение психических факторов в клинике внутренних болезней

Материал для специалистов

ЖУРНАЛЫ

ИНТЕРАКТИВ

СПЕЦИАЛИЗАЦИИ

ИЗДАНИЯ-ПАРТНЕРЫ

Значение психических факторов в клинике внутренних болезней

Материал для специалистов

Con-Med Passport